搜索临床试验以:ABI-007 (Abraxane) and Carboplatin
总计6363个结果
-
University Health Network, TorontoCelgene Corporation完全的
-
University of Alabama at BirminghamSusan G. Komen Breast Cancer Foundation; Daiichi Sankyo UK Ltd.; Triple Negative Breast Cancer...完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
University of Michigan Rogel Cancer CenterCelgene Corporation终止
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)终止
-
CelgeneUniversity of Arizona完全的
-
National Research Council, SpainHospital Universitario 12 de Octubre完全的
-
Chinese PLA General Hospital未知
-
Celgene完全的
-
University of WashingtonNational Cancer Institute (NCI); Celgene Corporation完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人复发性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 转移性乳腺癌 | 局部晚期乳腺癌美国
-
Mayo ClinicNational Cancer Institute (NCI)撤销
-
Celgene完全的癌,非小细胞肺癌 | 膀胱肿瘤 | 肿瘤病毒感染 | 卵巢肿瘤 | 输卵管肿瘤 | 腹膜肿瘤 | 癌,移行细胞 | 癌,胰腺导管西班牙, 美国, 法国, 荷兰
-
Adicet Bio, Inc邀请报名淋巴瘤,滤泡性 | 淋巴瘤,非霍奇金 | 淋巴瘤,套细胞 | 边缘区淋巴瘤 | 弥漫性大 B 细胞淋巴瘤 | 原发性纵隔 B 细胞淋巴瘤美国
-
Northwestern UniversityGlaxoSmithKline; Celgene Corporation完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的胰腺癌 | III 期胰腺癌 AJCC v6 和 v7 | 局部晚期胰腺癌 | 交界性可切除胰腺癌 | II 期胰腺癌 AJCC v6 和 v7 | IIA 期胰腺癌 AJCC v6 和 v7 | IIB 期胰腺癌 AJCC v6 和 v7美国
-
Anne NoonanNational Cancer Institute (NCI)招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中